Curocell (XKRX:372320) Pre-Tax Income : ₩ Mil (TTM As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Curocell Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Curocell's pretax income for the six months ended in Jun. 2023 was ₩-12,610.70 Mil. Curocell does not have enough years/quarters to calculate the pretax income for the trailing twelve months (TTM) ended in Jun. 2023. Curocell's pretax margin was %.

During the past 5 years, Curocell's highest Pretax Margin was -21407.56%. The lowest was -3759583.50%. And the median was -1890495.53%.

Curocell Pre-Tax Income Historical Data

The historical data trend for Curocell's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Pre-Tax Income Chart

Curocell Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

-15,038.33

-7,699.23

-53,575.67

-38,885.13

-29,663.58

Curocell Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	-26,212.14	-12,672.99	-12,610.70	-17,052.88

Competitive Comparison of Curocell's Pre-Tax Income

For the Biotechnology subindustry, Curocell's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curocell's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curocell's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Curocell's Pre-Tax Income falls into.

Curocell Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Curocell's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-31129.753	+	0	+	-2430.643	+	617.538	+	3279.275
	=	-29,663.58

Curocell's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-13975.252	+	0	+	-749.862	+	295.884	+	1818.528
	=	-12,610.70

Curocell (XKRX:372320) Pre-Tax Income Explanation

Curocell's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-12610.702	/	0
	=	%

During the past 5 years, Curocell's highest Pretax Margin was -21407.56%. The lowest was -3759583.50%. And the median was -1890495.53%.

Curocell Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Curocell's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002

Website

https://www.curocellbtx.com

Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines